Clinical Use of Platelet-Rich Plasma to Promote Tendon-Bone Healing and Graft Maturation in Anterior Cruciate Ligament Reconstruction-A Randomized Controlled Study.
Heng Gong, Bin Huang, Zhuozhao Zheng...
https://pubmed.ncbi.nlm.nih.gov/35103026/Actively Recruiting
Led by Lahore General Hospital · Updated on 2026-03-13
60
Participants Needed
1
Research Sites
13 weeks
Total Duration
Researchers are evaluating whether a single 4 ml injection of platelet-rich plasma PRP inside the knee can improve function after anterior cruciate ligament ACL reconstruction using a peroneus longus autograft. This randomized controlled trial involves 88 patients aged 18 to 50 years in Pakistan, a setting where cost-effective treatments are important. The study compares PRP with a saline placebo to see if PRP helps recovery and improves knee function scores over time. Participants receive arthroscopic ACL reconstruction with a peroneus longus autograft. During surgery, half of the patients are randomly assigned to get a 4 ml PRP injection 2 ml in each femoral and tibial tunnel, while the other half receive a saline injection as a placebo. PRP is prepared from the patients own blood using a single-spin centrifugation. The study measures knee function using KOOS4 scores at 3, 6, and 12 months after surgery. Patients will be assessed at baseline before surgery and then followed up at 3, 6, and 12 months with questionnaires to measure knee function and recovery. The study uses statistical methods to compare the groups while adjusting for baseline differences. Results could help guide affordable treatment options in similar resource-limited settings. The total participation lasts about one year, and the study monitors patient adherence to the rehabilitation and follow-up visits to ensure data quality.
CONDITIONS
Comparison of Functional Outcomes Following Arthroscopic ACL Reconstruction With Peroneus Longus Autograft With and Without Intra-articular Platelet-Rich Plasma Injection.
H
Hafiz Sohail Ahmad, Dr
A
Abdul Subhan Zahid, Dr
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Lahore General Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Surgery day and immediate recovery period
Participants undergo arthroscopic ACL reconstruction with peroneus longus autograft and receive either a single intra-articular platelet-rich plasma (PRP) injection or saline during surgery.
1 surgery visit (in-person)
Duration - 12 months
Participants are assessed for functional outcomes and recovery using validated KOOS4 questionnaires integrated into clinic visits.
Visits at baseline, 3 months, 6 months, and 12 months (in-person)
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Heng Gong, Bin Huang, Zhuozhao Zheng...
https://pubmed.ncbi.nlm.nih.gov/35103026/Yi Cao, Ye-da Wan
https://pubmed.ncbi.nlm.nih.gov/36056588/Kyle N Kunze, Jeevana J Pakanati, Amar S Vadhera...
https://pubmed.ncbi.nlm.nih.gov/35155701/Lahore General Hospital
Lead Sponsor